Evidence map›Paper›PMID 41777521›Full record

ArticleJournal of oral microbiology2026

Oral microbiota composition in children and adults during Spanish COVID-19 lockdown: impact of home self-confinement and SARS-CoV-2 infection.

Miguel Blanco-Fuertes, Gerard González-Comino, Pedro Brotons, Aleix Lluansí, Rosauro Varo, Desirée Henares, Cristian Launes, Maria Cisneros, Mariona F de Sevilla, Juan J García-García and 3 more

Abstract read
In one paragraph

Article in Journal of oral microbiology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors.

Miguel Blanco-FuertesInfectious Diseases and Microbiome Research Group, Institut de Recerca Sant Joan de Déu, Hospital Sant Joan de Déu, Barcelona, Spain.ORCID https://orcid.org/0000-0002-8251-0682
Gerard González-CominoInfectious Diseases and Microbiome Research Group, Institut de Recerca Sant Joan de Déu, Hospital Sant Joan de Déu, Barcelona, Spain.ORCID https://orcid.org/0009-0005-2678-4397
Pedro BrotonsInfectious Diseases and Microbiome Research Group, Institut de Recerca Sant Joan de Déu, Hospital Sant Joan de Déu, Barcelona, Spain.ORCID https://orcid.org/0000-0002-2399-7320
Aleix LluansíInfectious Diseases and Microbiome Research Group, Institut de Recerca Sant Joan de Déu, Hospital Sant Joan de Déu, Barcelona, Spain.ORCID https://orcid.org/0000-0002-2328-6780
Rosauro VaroInfectious Diseases and Microbiome Research Group, Institut de Recerca Sant Joan de Déu, Hospital Sant Joan de Déu, Barcelona, Spain.ORCID https://orcid.org/0000-0003-4282-5572
Desirée HenaresInfectious Diseases and Microbiome Research Group, Institut de Recerca Sant Joan de Déu, Hospital Sant Joan de Déu, Barcelona, Spain.ORCID https://orcid.org/0000-0003-2631-2718
Cristian LaunesInfectious Diseases and Microbiome Research Group, Institut de Recerca Sant Joan de Déu, Hospital Sant Joan de Déu, Barcelona, Spain.ORCID https://orcid.org/0000-0002-0913-9303
Maria CisnerosInfectious Diseases and Microbiome Research Group, Institut de Recerca Sant Joan de Déu, Hospital Sant Joan de Déu, Barcelona, Spain.ORCID https://orcid.org/0009-0001-9715-887X
Mariona F de SevillaInfectious Diseases and Microbiome Research Group, Institut de Recerca Sant Joan de Déu, Hospital Sant Joan de Déu, Barcelona, Spain.ORCID https://orcid.org/0000-0003-3104-675X
Juan J García-GarcíaInfectious Diseases and Microbiome Research Group, Institut de Recerca Sant Joan de Déu, Hospital Sant Joan de Déu, Barcelona, Spain.ORCID https://orcid.org/0000-0002-3483-528X
Alex MiraConsorcio de Investigación Biomédica en Red de Epidemiología y Salud Pública (CIBERESP), Instituto de Salud Carlos III, Madrid, Spain.ORCID https://orcid.org/0000-0002-9127-3877
Quique BassatConsorcio de Investigación Biomédica en Red de Epidemiología y Salud Pública (CIBERESP), Instituto de Salud Carlos III, Madrid, Spain.ORCID https://orcid.org/0000-0003-0875-7596
Carmen Muñoz-AlmagroInfectious Diseases and Microbiome Research Group, Institut de Recerca Sant Joan de Déu, Hospital Sant Joan de Déu, Barcelona, Spain.ORCID https://orcid.org/0000-0001-5586-404X

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background: The COVID-19 pandemic altered societal habits due to social restrictions and health measures implemented during the first half of 2020. Objective: This study aimed to evaluate the association between oral microbiota composition and age, household cohabitation, SARS-CoV-2 infection, and COVID-19 severity among children and adults under home confinement in Barcelona, Spain. Design: A prospective study was conducted between April and June 2020 in the Barcelona Metropolitan Area, including children and adults confined during the pandemic. Multiple participants from the same family households were enrolled. Saliva samples were collected from all participants, and oral microbiota composition was characterized using 16S rRNA gene sequencing. Results: A total of 142 adults and 265 children from 121 households were included. All adults had confirmed SARS-CoV-2 infection, and 20 (14.08%) experienced severe COVID-19. Among children, 58/265 (21.89%) tested positive; all were asymptomatic. In children, oral microbiota diversity and composition did not differ by infection status. In adults, severe COVID-19 was associated with lower diversity and distinct composition compared with mild disease. Marked age-related differences were observed in younger children. Cohabiting individuals shared more amplicon sequence variants than non-cohabitants. Conclusions: Age and cohabitation strongly influenced oral microbiota composition. In adults, microbiota varied with COVID-19 severity, whereas no differences were observed among asymptomatic children.

Indexed as

16S rRNA geneCOVID-19lockdownOral microbiotaSARS-CoV-2

Identifiers

PMID41777521
PMCPMC12951666

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.